Crossbow Therapeutics
Cambridge, United States · Founded 2023 · $157.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- crossbowtherapeutics.com
- Total Funding
- $157.0M
- Last Round
- $77.0M Series BMar 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biotech developing T-cell engager bispecific antibodies (T-Bolts) for cancer immunotherapy; Phase 1 trial ongoing.
Summary
Crossbow Therapeutics is a Biotech company based in Cambridge, United States, founded in 2023. It has raised $157.0M in total across 2 rounds, most recently a $77.0M Series B round in Mar 2026. Investors include MPM BioImpact and Pfizer Ventures.
Funding History
Mar 2026
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/crossbow-therapeutics"><img src="https://indexed.vc/api/badge/company/crossbow-therapeutics" alt="Crossbow Therapeutics on Indexed.vc" width="260" height="76" /></a>